How Primary Care Physicians Can Approach the Use of GLP-1 Receptor Agonists for Weight Loss
Michael Crotty, MD, provides practical guidance for on integrating GLP-1 receptor agonists into a comprehensive obesity treatment plan.
Teresa Lovins, MD: Primary Care Tools for Screening Mood and Behavioral Disorders
Teresa Lovins, MD, describes the PHQ-9, GAD-7, and other brief screeners that help family physicians identify depression, anxiety, ADHD, and bipolar disorder in everyday practice.
Salt Substitute Use Remains Rare Among US Adults With Hypertension, Two-Decade Survey Finds
Analysis presented at AHA Hypertension 2025 showed fewer than 6% of US adults use salt substitutes, despite their potential to improve BP control.
FDA OKs Semaglutide 2.4 mg for Treatment of MASH Without Cirrhosis: Daily Dose
Your daily dose of the clinical news you may have missed.
Weekly Dose Podcast: Psoriasis Drug Success, Intranasal Insulin Insights, and New Data on Vaccines and GLP-1 Use
This week’s podcast covers psoriasis trial results, intranasal insulin, COVID-19 booster safety, GLP-1 use in diabetes, and RSV vaccine uptake.
High-Dose Influenza Vaccine Reduces Risk of Myocarditis and Pericarditis in Older Adults
A secondary analysis of the DANFLU-2 trial found adults ≥65 receiving a high-dose flu vaccine had a 46% lower risk of myocarditis or pericarditis compared with standard-dose vaccination.
Data Show Many US Adults Lack Awareness About HPV, Vaccine: Daily Dose
The Future of GLP-1RAs in Obesity Treatment: Expert Perspective
With the surge in demand and supply shortages, Michael Crotty, MD, discusses the future of GLP-1RA use in the treatment of obesity.
Study Links Older Age and Low Fitness to Higher Risk of Arrhythmias in Healthy Adults
Research reveals that older age and lower aerobic fitness significantly increase the risk of arrhythmias, highlighting the need for early screening and fitness maintenance.
US Counties With Low Screening See Higher Cervical Cancer Death Rates: Daily Dose
GLP-1RAs for Weight Management: Weighing Benefits vs Side Effects
Obesity medicine specialist Michael Crotty, MD, discusses the benefits of GLP-1 receptor agonist use in weight management and its impact on obesity-related comorbidities.
FDA Approves Automated Insulin Delivery System for Adults With Type 2 Diabetes
FDA clears MiniMed 780G for integration with Abbott’s Instinct sensor and approves its use in insulin-requiring T2D, expanding automated insulin delivery options.
Data Shows Initial RSV Vaccine Uptake is Low Among Older Adults: Daily Dose
Oral PCSK9 Inhibitor Enlicitide Meets All End Points in Phase 3 Hypercholesterolemia Trial
At week 24, patients receiving once-daily enlicitide demonstrated statistically significant and clinically meaningful reductions in low-density lipoprotein cholesterol compared with placebo.
Overcoming Barriers in Obesity and Hypertension Management: Practical Strategies for Physicians
Caissa Troutman, member of the Obesity Medicine Association, emphasizes the importance of shared decision-making in overcoming barriers.
Real-World Study: Semaglutide Lowers Cardiovascular Risk More Than Tirzepatide in Adults With Obesity and CVD
At ESC 2025, the STEER study showed semaglutide reduced risk of heart attack, stroke, or death by 57% vs tirzepatide in adults with obesity and cardiovascular disease, complementing prior trial data.
FDA Approves Brensocatib for Non–Cystic Fibrosis Bronchiectasis: Daily Dose
FDA Approves Subcutaneous Leqembi Autoinjector for Maintenance Therapy in Early Alzheimer Disease
The FDA has cleared Eisai and Biogen’s Leqembi Iqlik, the first at-home subcutaneous autoinjector for maintenance therapy in patients with early Alzheimer disease.
More Than One-Third of Middle-Aged Adults with Diabetes Prescribed GLP-1 RAs: Daily Dose
Updated COVID-19 Vaccines Are Approved, But Population Restrictions Concern Experts
Seniors remain protected along with any adult or child with underlying risk factors for severe disease, but the healthy US population is left with a choice, so far.
.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "How Primary Care Physicians Can Approach the Use of GLP-1 Receptor Agonists for Weight Loss")
.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "Overcoming Barriers in Obesity and Hypertension Management: Practical Strategies for Physicians / Image credit: ©MJH Life Sciences")
